Posts Tagged ‘Trlipix’

May 19th, 2011

FDA Panel Delivers Mixed Verdict on Trilipix (Fenofibrate)

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee delivered a mixed verdict on fenofibrate (Trilipix, Abbott). On the one hand, the panel agreed unanimously that the FDA should require Abbott to perform a large clinical trial in high-risk patients with elevated triglyceride levels and low HDL levels who nevertheless have achieved target LDL cholesterol levels […]